研究目的
Investigating the therapeutic effects of self-assembled naphthalimide conjugated porphyrins nanomaterials with D-A structure for PDT/PTT synergistic therapy.
研究成果
The as-prepared porphyrin-based nanoparticles demonstrated good biocompatibility, efficient ROS generation, and high photothermal conversion efficiencies, making them promising nanoagents for PDT/PTT synergistic cancer therapy.
研究不足
The study is limited to in vitro experiments, and further in vivo studies are needed to evaluate the therapeutic efficacy and safety of the nanoparticles.
1:Experimental Design and Method Selection
Two new organic porphyrin molecules (NI-Por and NI-ZnPor) with donor (D)-acceptor (A) structure were designed and synthesized. The nanoparticles were prepared through the nanoprecipitation method.
2:Sample Selection and Data Sources
HeLa cells were used for in vitro experiments to evaluate the photocytoxicity and intracellular ROS generation.
3:List of Experimental Equipment and Materials
JEM-2100 transmission electron microscopy (TEM), Zetasizer NanoZS 90 system (Malvern U.K.), Confocal Laser Scanning Fluorescence Microscope (FV1200) from Olympus, Japan.
4:Experimental Procedures and Operational Workflow
The nanoparticles were characterized by TEM, DLS, and fluorescence spectroscopy. The photocytotoxicity was evaluated through CCK-8 assay, and intracellular ROS generation was confirmed using DCFH-DA as an indicator.
5:Data Analysis Methods
The photothermal conversion efficiency was calculated based on the temperature changes under laser irradiation. The singlet oxygen quantum yield was measured using ABDA as a capture reagent.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容